This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2024 Feb 26;10(1):23.

doi: 10.1038/s41421-024-00660-5.

Author Correction: Pharmacology of LRRK2 with type I and II kinase inhibitors revealed by cryo-EM

Hanwen Zhu¹, Patricia Hixson¹, Wen Ma², Ji Sun³

Affiliations

Affiliations

¹ Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
² Department of Physics, University of Vermont, Burlington, VT, USA. wen.ma@uvm.edu.
³ Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. ji.sun@stjude.org.

PMID: 38409077
PMCID: PMC10897174
DOI: 10.1038/s41421-024-00660-5

Published Erratum

Author Correction: Pharmacology of LRRK2 with type I and II kinase inhibitors revealed by cryo-EM

Hanwen Zhu et al. Cell Discov. 2024.

. 2024 Feb 26;10(1):23.

doi: 10.1038/s41421-024-00660-5.

Authors

Hanwen Zhu¹, Patricia Hixson¹, Wen Ma², Ji Sun³

Affiliations

¹ Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
² Department of Physics, University of Vermont, Burlington, VT, USA. wen.ma@uvm.edu.
³ Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA. ji.sun@stjude.org.

PMID: 38409077
PMCID: PMC10897174
DOI: 10.1038/s41421-024-00660-5

No abstract available

PubMed Disclaimer

Erratum for

Pharmacology of LRRK2 with type I and II kinase inhibitors revealed by cryo-EM.
Zhu H, Hixson P, Ma W, Sun J. Zhu H, et al. Cell Discov. 2024 Jan 23;10(1):10. doi: 10.1038/s41421-023-00639-8. Cell Discov. 2024. PMID: 38263358 Free PMC article.

Similar articles

Pharmacology of LRRK2 with type I and II kinase inhibitors revealed by cryo-EM.
Zhu H, Hixson P, Ma W, Sun J. Zhu H, et al. Cell Discov. 2024 Jan 23;10(1):10. doi: 10.1038/s41421-023-00639-8. Cell Discov. 2024. PMID: 38263358 Free PMC article.
Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes.
Sejwal K, Chami M, Rémigy H, Vancraenenbroeck R, Sibran W, Sütterlin R, Baumgartner P, McLeod R, Chartier-Harlin MC, Baekelandt V, Stahlberg H, Taymans JM. Sejwal K, et al. Sci Rep. 2017 Aug 17;7(1):8667. doi: 10.1038/s41598-017-09126-z. Sci Rep. 2017. PMID: 28819229 Free PMC article.
Inhibition of Parkinson's disease-related LRRK2 by type I and type II kinase inhibitors: Activity and structures.
Sanz Murillo M, Villagran Suarez A, Dederer V, Chatterjee D, Alegrio Louro J, Knapp S, Mathea S, Leschziner AE. Sanz Murillo M, et al. Sci Adv. 2023 Dec;9(48):eadk6191. doi: 10.1126/sciadv.adk6191. Epub 2023 Dec 1. Sci Adv. 2023. PMID: 38039358 Free PMC article.
Structural Biology of LRRK2 and its Interaction with Microtubules.
Leschziner AE, Reck-Peterson SL. Leschziner AE, et al. Mov Disord. 2021 Nov;36(11):2494-2504. doi: 10.1002/mds.28755. Epub 2021 Aug 23. Mov Disord. 2021. PMID: 34423856 Free PMC article. Review.
Leucine-rich repeat kinase 2 inhibitors: a review of recent patents (2011 - 2013).
Kethiri RR, Bakthavatchalam R. Kethiri RR, et al. Expert Opin Ther Pat. 2014 Jul;24(7):745-57. doi: 10.1517/13543776.2014.907275. Epub 2014 Jun 11. Expert Opin Ther Pat. 2014. PMID: 24918198 Review.

See all similar articles

Publication types

Actions

LinkOut - more resources

Full Text Sources